Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Lithium can cause skin issues like acne and hair loss.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.